Trial NCT02842125

View at ClinicalTrials.gov 
Org. Study IDs: MultiVir Ad-p53-001

Last trial update was posted on 2020-06-02

MeSH Interventions

Capecitabine Nivolumab Pembrolizumab

MeSH Conditions

Recurrence

Other Conditions

Metastatic Solid Tumor Cancer Recurrent Head and Neck Cancer

Stopping Reasons

Arm C rolled into parallel study; Arms A and B halted for greater efficacy in Arm C

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID